• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:李文龙,王雪蕾,谭丽媛,魏京京,吴朝阳,姚尚辰,黄海伟,孙会敏.境外生产化学药品注册检验工作机制创新研究[J].药学研究,2025,44(3):296-301[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2161次   下载 759次 本文二维码信息
码上扫一扫!
境外生产化学药品注册检验工作机制创新研究
李文龙,王雪蕾,谭丽媛,魏京京,吴朝阳,姚尚辰,黄海伟,孙会敏
字体:加大+|默认|缩小-
(中国食品药品检定研究院,国家药品监督管理局化学药品质量研究与评价重点实验室,药品监管科学全国重点实验室,北京 102629)
摘要:
目的 开展药品监管科学研究,为高质量完成境外生产化学药品注册检验创新工作机制。方法 按照资料审核、标准复核、标准审核三个阶段,梳理总结注册检验工作中突出的共性问题,适应《药品注册管理办法》工作要求,提出创新工作机制,进行实践探索,比较工作机制运行前后品种的注册检验用时和效率。结果 与新《药品注册管理办法》实施前相比,新机制运行后资料审核阶段资料接收用时从11.2个自然日缩短至1.4日,标准复核阶段用时缩短62%,标准审核阶段审核等待用时从20.5个工作日缩短至1日。结论 通过开展资料并联审核、优化品种分配、报告即到即审等创新举措建立的新工作机制,有效提升了境外生产化学药品注册检验的工作效率,精简了程序步骤,缩短了检验用时,已成为高质量完成境外生产化学药品注册检验的重要基石,可将创新工作机制推广应用至全品种注册检验,促进创新药品加速上市。
关键词:  境外生产化学药品  注册检验  工作机制  资料审核  监管科学
DOI:10.13506/j.cnki.jpr.2025.03.014
基金项目:国家药品监督管理局化学药品质量研究与评价重点实验室项目(No.2023HYZX32);中国食品药品检定研究院中青年发展研究基金项目(No.2019G1)
出版日期:2025-03-25
Study on the innovation of working mechanism of registration and inspection for overseas production of chemical drugs
LI Wenlong,WANG Xuelei,TAN Liyuan,WEI Jingjing,WU Zhaoyang,YAO Shangchen,HUANG Haiwei,SUN Huimin
(NMPA Key Laboratory for Quality Research and Evaluation of Chemical Drugs,State Key Laboratory of Drug Regulatory Science,National Institutes for Food and Drug Control, Beijing 102629, China)
Abstract:
Objective To carry out scientific research on drug regulation, innovative working mechanism for the completion of high-quality registration and inspection of overseas production of chemical drugs. Methods According to the information review, standard review, standard audit three stages, sorting and summarizing the common problems highlighted in the registration and inspection work, to adapt to the “Administrative Measures for Drug Registration” work requirements, put forward an innovative working mechanism for practical exploration, comparison of working mechanisms before and after the operation of the variety of registration and inspection time and efficiency.Results Compared with the new “Administrative Measures for Drug Registration” before the implementation of the new mechanism, the new mechanism after the operation of the data review phase of the data received from 11.2 natural days to shorten the time to 1.4 days, 62% shorter than the standard review stage, the standard review stage audit waiting time from 20.5 working days to 1 day. Conclusion By carrying out parallel review of information, optimize the allocation of species, the report that is the review of innovative initiatives to establish a new working mechanism, effectively improve the efficiency of the registration and inspection of overseas production of chemical drugs, streamline the procedures and steps to shorten the test time, has become an important cornerstone of the high-quality completion of the registration and inspection of overseas production of chemical drugs, can be extended to the full range of innovative working mechanisms to promote the registration and inspection of innovative medicines. The innovative working mechanism can be extended and applied to the registration and inspection of all varieties, thus promoting the accelerated listing of innovative drugs.
Key words:  Overseas production of chemical drugs  Registration and testing  Working mechanism  Data review  Front  parallel  Regulatory science
今日访问量:2657    总访问量:55339174
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司